Skip to content

The impact of 2-week preoperative walking training on clinical outcomes of surgical lung cancer patients:: A randomized controlled trial

The impact of 2-week preoperative walking training on clinical outcomes of surgical lung cancer patients:: A randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036453
Enrollment
Unknown
Registered
2020-08-23
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Group 2:Walk more than 7000 steps a day for 2 weeks
Group 1:Non-pre-surgery movement

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective pulmonary resection; 2. Aged >=18 years old; 3. BMI less than 35; 4. The expected operation time was no more than 3 hours; 5. General anesthesia with double lumen endotracheal intubation.

Exclusion criteria

Exclusion criteria: 1. History of VTE; 2. Varicose veins of lower limbs; 3. Hereditary or acquired thrombosis tendency; 4. Patients with cardiovascular and cerebrovascular diseases received anticoagulant therapy; 5. Chronic obstructive pulmonary disease gold grade III and IV, pulmonary fibrosis, pulmonary bullae, severe emphysema, pneumothorax; 6. Asthma requiring medication control; 7. NYHA grade 3 and 4 for heart failure and CCS grade 3 and 4 for coronary heart disease; 8. History of pulmonary surgery; 9. The recorded pulmonary hypertension was greater than 25mmhg, and the mean pulmonary artery pressure was greater than 40mmhg at rest (determined by ultrasonic evaluation); 10. There were muscle, bone and joint diseases, and the movement was not changed; (1) Sleeve pneumonectomy or pneumonectomy was performed; (2) Mechanical ventilation was planned after operation; (3) General anesthesia without intubation was planned; (4) Participate in other intervention studies or refuse to sign informed consent form; (5) Pregnancy; (6) Athletes or those who have been engaged in sports for a long time; (7) Other special cases.

Design outcomes

Primary

MeasureTime frame
Postoperative pulmonary complications;Perioperative venous thromboembolism;

Secondary

MeasureTime frame
30-day mortality;

Countries

China

Contacts

Public ContactYu-Gang Lu

Shanghai Pulmonary Hospital

luyugang2018@aliyun.com+86 13524682653

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026